← Back to Directory

Royalty Pharma plc (RPRX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Royalty Pharma plc (RPRX).

Download StockRank on Google Play Download StockRank on the App Store

Equity Details

Price & Market Data

Price: $51.70

Daily Change: +$0.05 / 0.10%

Daily Range: $50.54 - $52.15

Market Cap: $29,770,524,672

Daily Volume: 3,446,085

Performance Metrics

1 Week: 2.50%

1 Month: 6.75%

3 Months: 16.94%

6 Months: 34.08%

1 Year: 55.02%

YTD: 33.80%

About Royalty Pharma plc (RPRX)

Stay informed with Royalty Pharma plc (RPRX) market data. Current price: 51.70, daily change: +$0.05 / 0.10%. Market cap: 29,770,524,672. Performance over 1-month, 3-month, and 1-year.

Company Details

Employees: 100

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Selected stocks

Lyft, Inc. (LYFT)

Siddhi Acquisition Corp (SDHI)

Epsilon Energy Ltd. (EPSN)

Sound Point Meridian Capital, Inc. 8.00% Series A Preferred Shares Due 2029 (SPMA)

Sound Group Inc. (SOGP)